Truist cuts American Express stock price target on capital concerns By Investing.com

Truist cut its American Express (AXP) price target to $360 from $400 while maintaining a Buy; the stock trades at $302.20 and is down ~20% YTD. Truist raised 2026 EPS to $18.00 (+1%), trimmed Q1-2026 variable customer engagement to 45% and lowered net charge-offs to 2.1%, but warned of potential risk‑weighted asset inflation from the Fed capital proposal and uncertainty around an operational risk add‑on. U.S. Consumer card loans fell to $95.1B in February (from $97.2B in Jan), 30‑day delinquencies held at 1.4%, and analyst price targets vary widely from $285 (BTIG, Sell) to $425 (RBC, Outperform).

Analysis

The regulatory noise around operational risk-weighted assets creates an asymmetric vulnerability for franchise-style card issuers that operate as quasi-banks. If regulators treat interest-and-fee income tied to revolving lines as a higher-risk bucket, expect a multi-year drag on reported ROE unless the company either raises capital, accelerates securitization, or materially tightens credit — each path compresses EPS growth differently and forces trade-offs between shareholder returns and loan growth.

Credit-health signals are currently mixed: headline delinquency rates are benign but loan balances are trending down, which looks more like active portfolio management than systemic stress. That pattern raises the probability that management will prioritize capital-light growth (co-brand deals, interchange optimization, fee income) over unsecured loan growth, shifting revenue mix and making EPS less levered to consumer spend — a structural rerating risk over 12–36 months.

From a competitive standpoint, banks with deposit franchises and issuers embedded in clearing rails have optionality that specialty card players lack; those banks can absorb incremental RWAs more cheaply and can monetize higher-spend cohorts at scale. A swift regulatory clarification that narrows the operational add-on would be a high-gamma catalyst to the upside, whereas a broad interpretation that captures interest/fee flows would be a multi-quarter negative requiring capital offset actions and likely multiple compression.

Key Decisions for Investors

• Pair trade (6–12 months): Short AXP vs Long BAC — size 2–4% net exposure. Rationale: expect relative ROE compression at franchise card issuers if RWAs rise; target 15–25% relative outperformance for BAC. Risk management: tighten or rebalance if AXP outperforms its 3-month trend by >7%.
• Defined-risk hedge (3–6 months): Buy AXP put spread (debit put spread) to protect downside from a regulatory surprise. Aim for a 1:2 risk/reward where max loss = premium and target payoff ~20–30% downside in share value; use as portfolio tail hedge around earnings/regulatory commentary windows.
• Event-style asymmetric long (3–9 months): Buy AXP call spread ahead of potential regulatory clarification or softer-than-expected guidance on RWA scope. Small premium exposure (~1% portfolio) with upside if Fed narrows operational add-on; close quickly on sign of constructive language.
• Sector rotation (6–12 months): Overweight large-bank credit (e.g., BAC) and underweight specialty card issuers — implement via ETFs or equal-dollar pair to capture spread compression if capital rules crystallize. Monitor consumer credit metrics and regulatory milestones; reduce position if loan-growth divergence reverses within two consecutive quarters.